NUVL Competitors & Alternatives
Compare Nuvalent Inc with similar stocks in the same industry
Biotechnology
NUVL
Main Stock$123.96
Tradestie Score
44
Market Cap
$5.95B
Analyst Upside
+0.9%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.85
|
$10.76B | - | 42 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$248.69
|
$10.74B | - | 34 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.33
|
$10.53B | - | 56 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$28.33
|
$10.49B | - | 50 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$79.00
|
$10.22B | - | 33 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$433.03
|
$10.01B | - | 56 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.80
|
$9.33B | 66.8 | 52 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$74.53
|
$8.88B | 56.4 | 53 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$101.68
|
$8.77B | 25.7 | 51 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$180.70
|
$8.57B | - | 53 | Compare |
More NUVL Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry